Combined Effects of Aerobic Exercise and Cognitive Training on Cognition After Stroke
NCT ID: NCT01674790
Last Updated: 2018-03-23
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
22 participants
INTERVENTIONAL
2013-10-13
2017-06-16
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Synergistic Effects of Aerobic Exercise and Cognitive Training on Cognition in Stroke Patients With Cognitive Decline
NCT02550990
Stepping up Aerobic Exercise to Improve Health Outcomes After Stroke
NCT02296268
Exercise and Cognition Among Stroke Survivors
NCT06848998
Aerobic Exercise and Cognitive Training in Older Adults
NCT02787655
Reshaping the Path of Mild Cognitive Impairment by Refining Exercise Prescription
NCT02737878
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Cognitive training: Computerized dual n-back training program that involves a working memory task, the difficulty of which adapts to the individual participant's performance.
ROM exercise: Non-aerobic passive and active movement of upper and lower extremity joints performed with the subject lying on a plinth. RPE will be recorded every 5 minutes to ensure intensity remains low. Mental activities: Unstructured mental activity: such as listening to light novels on tape, which will be selected by the subject from a pre-determined list.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
FACTORIAL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
AEROBIC group
6-week program of one 20-min session of aerobic training and one 20-min session of ROM exercise 5 days/week.
Aerobic training
One 20-min session of body weight support treadmill training at moderate to high intensity (60-70% heart rate reserve) 5 days/week for 6-weeks.
Range of motion exercise
One 20-min session of range of motion exercise (non-aerobic passive and active movement of upper and lower extremity) 5 days/week for 6-weeks.
COGNITIVE group
6-week program of one 20-min session of cognitive training and one 20-min session of ROM exercise 5 days/week.
Cognitive training
One 20-min session of cognitive training (computerized dual n-back training program) 5 days/week for 6 weeks.
Range of motion exercise
One 20-min session of range of motion exercise (non-aerobic passive and active movement of upper and lower extremity) 5 days/week for 6-weeks.
AEROBIC + COGNITIVE group
6-week program of one 20-min session of aerobic training and one 20-min session of cognitive training 5 days/week.
Aerobic training
One 20-min session of body weight support treadmill training at moderate to high intensity (60-70% heart rate reserve) 5 days/week for 6-weeks.
Cognitive training
One 20-min session of cognitive training (computerized dual n-back training program) 5 days/week for 6 weeks.
CONTROL group
6-week program of one 20-min session of ROM exercise and one 20-min session of unstructured mental activity 5 days/week.
Range of motion exercise
One 20-min session of range of motion exercise (non-aerobic passive and active movement of upper and lower extremity) 5 days/week for 6-weeks.
Unstructured mental activity
One 20-min session of unstructured mental activity (e.g., listening to light novels on tape) 5 days/week for 6-weeks.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Aerobic training
One 20-min session of body weight support treadmill training at moderate to high intensity (60-70% heart rate reserve) 5 days/week for 6-weeks.
Cognitive training
One 20-min session of cognitive training (computerized dual n-back training program) 5 days/week for 6 weeks.
Range of motion exercise
One 20-min session of range of motion exercise (non-aerobic passive and active movement of upper and lower extremity) 5 days/week for 6-weeks.
Unstructured mental activity
One 20-min session of unstructured mental activity (e.g., listening to light novels on tape) 5 days/week for 6-weeks.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Diagnosis of ischemic or hemorrhagic stroke \>6months ago
* Be able to perform a two-step command
* Be able to walk ≥10m with/without aid
* Live within a 75km radius of the QE II
* Pass a cardiology screen for safe participants in exercise training
Exclusion Criteria
* Have terminal illness, life-threatening co-morbidity or concomitant neurological or psychiatric illness
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Nova Scotia Health Research Foundation
OTHER_GOV
Dalhousie University
OTHER
Heart and Stroke Foundation of Canada
OTHER
Marilyn MacKay-Lyons
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Marilyn MacKay-Lyons
Affiliated Scientist
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Marilyn MacKay-Lyons, PhD
Role: PRINCIPAL_INVESTIGATOR
Dalhousie University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Nova Scotia Rehabilitation Centre
Halifax, Nova Scotia, Canada
School of Physiotherapy, Dalhousie University
Halifax, Nova Scotia, Canada
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Priming Study
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.